Latest News

No Results Found

Try adjusting your search to find what you’re looking for.


Company Spotlight – Rebus Biosystems

“This technology is an incredible tool,” said Illumina Ventures partner, Tom Willis, PhD. “By enabling researchers to study cellular and molecular interactions in their native contexts while delivering tens of millions of data points from hundreds of thousands of cells in a matter of days, the Rebus Esper spatial omics platform is ushering in a new era of biology.”

Read More

Bloomberg: Health Startup Backed by Golfer McIlroy Reaches $1 Billion Value

Virtual health-care startup LetsGetChecked has raised $150 million in new financing to expand its business after seeing a boom in demand for its services during the pandemic. The funding round, which was led by Casdin Capital, valued the startup at more than $1 billion, Chief Executive Officer Peter Foley said in an interview. Other investors included CommonFund Capital, Illumina Ventures, Optu...

Read More

Company Spotlight – LetsGetChecked

“The pandemic has accelerated the development of LetsGetChecked and the telehealth field by at least 3-5 years,” says Nick Naclerio, Ph.D., Founding Partner at Illumina Ventures. “We anticipated some tailwinds from COVID-19 testing. But we were blown away by the speed at which the company managed to scale to the challenge.”

Read More

Delfi Diagnostics Announces $100 Million Series A

Delfi Diagnostics, Inc., a pioneering developer of a new class of high performance, affordable liquid biopsy tests for early cancer detection, has raised $100 million in Series A funding. {Illumina Ventures participated in the round.} Delfi plans to use this round of funds to expand its team of cancer researchers and machine learning experts and to validate its novel next-generation liquid bio...

Read More